NCT03943186

Application of Ectoin Containing Lozenges (EHT02) in Patients With Acute, Viral Pharyngitis.

Non-interventional Study to Investigate the Application of Ectoin Containing Lozenges (EHT02) in Patients With Acute, Viral Pharyngitis.

• Status: Completed
• Phase: —
• Study type: Observational
• Enrollment: 102 (actual)
• Sponsor: Bitop AG · Industry
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

The goal of this non-interventional study is to investigate the safety, efficacy and tolerability of Ectoin Lozenges Honey Lemon (EHT02) compared to lozenges containing hyaluronic acid and islandic moss in the treatment of acute viral pharyngitis.

Detailed description

The current non-interventional study aims to investigate the efficacy and tolerability of Ectoin Lozenges Honey Lemon in patients suffering from acute viral pharyngitis. Participants receive treatments as part of routine medical care, and participants can choose one of two treatment options: a) Ectoin Lozenges Honey Lemon or b) lozenges containing hyaluronic acid and icelandic moss. Efficacy will be studied by documentation of the following symptoms: * pain on swallowing * hoarseness * urge to cough * dry mouth and throat * redness of oropharynx and larynx * sore throat * impairment of free breathing * general feeling of illness In parallel, participating patients will document their symptoms over the entire study duration in patient diaries. The observation takes place over a period of seven days.

Conditions

• Acute Viral Pharyngitis

Interventions

Type	Name	Description
DEVICE	Ectoin Lozenges Honey Lemon	application of Ectoin Lozenges (EHT02) in accordance with the instructions for use
DEVICE	Hyaluronic Acid/Icelandic moss Lozenges	application of the lozenges in accordance with the instructions for use

Timeline

• Start date: 2018-12-13
• Primary completion: 2019-05-13
• Completion: 2019-05-13
• First posted: 2019-05-09
• Last updated: 2019-07-10

Locations

1 site across 1 country: Germany